Login / Signup

Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma.

Sureerat PadthaisongMalinee ThaneeNisana NamwatJutarop PhetcharaburaninPoramate KlanritNarong KhuntikeoAttapol TitapunSakkarn SungkhamanonHideyuki SayaWatcharin Loilome
Published in: Journal of translational medicine (2020)
The overexpression of CD44, CD44v6, CD44v8-10 and EpCAM increases predictability of post-operative CCA recurrence. Moreover, the overexpression of the panel of CSC markers combined with CA19-9 could improve our predictive ability for tumor recurrence in early stage CCA patients. This result may be beneficial for the patients in order to predict the outcome after treatment and may be useful for clinical intervention in order to improve patient survival.
Keyphrases